Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial

Leukemia. 2009 Mar;23(3):608-10. doi: 10.1038/leu.2008.248. Epub 2008 Sep 18.

Authors

E Willems, F Baron, E Baudoux, N Wanten, L Seidel, J-F Vanbellinghen, C Herens, A Gothot, P Frère, C Bonnet, K Hafraoui, G Vanstraelen, G Fillet, Y Beguin

PMID: 18800147
DOI: 10.1038/leu.2008.248

No abstract available

Publication types

Clinical Trial, Phase II
Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
CD8-Positive T-Lymphocytes / immunology*
Carcinoma, Renal Cell / secondary
Carcinoma, Renal Cell / surgery
Disease-Free Survival
Female
Follow-Up Studies
Hematologic Neoplasms / surgery*
Humans
Immunosuppressive Agents / therapeutic use
Kaplan-Meier Estimate
Kidney Neoplasms / pathology
Lymphocyte Depletion*
Male
Middle Aged
Myelodysplastic Syndromes / surgery
Myeloproliferative Disorders / surgery
Peripheral Blood Stem Cell Transplantation / methods*
Peripheral Blood Stem Cell Transplantation / statistics & numerical data
Transplantation Conditioning / methods*
Transplantation, Homologous
Vidarabine / analogs & derivatives
Vidarabine / therapeutic use
Whole-Body Irradiation

Substances

Immunosuppressive Agents
Vidarabine
fludarabine